Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies - Wikidata - wikimedia - TriplyDB

Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies

Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies

http://www.wikidata.org/entity/Q35182967

about

Pharmacological activation of the EDA/EDAR signaling pathway restores salivary gland function following radiation-induced damage Pharmacological stimulation of Edar signaling in the adult enhances sebaceous gland size and function Antagonistic Functions of USAG-1 and RUNX2 during Tooth Development Understanding cytokine and growth factor receptor activation mechanisms.Therapeutic blockade of LIGHT interaction with herpesvirus entry mediator and lymphotoxin β receptor attenuates in vivo cytotoxic allogeneic responses Ectodysplasin A Pathway Contributes to Human and Murine Skin Repair.Ectodysplasin signalling deficiency in mouse models of hypohidrotic ectodermal dysplasia leads to middle ear and nasal pathology.Generation and characterization of function-blocking anti-ectodysplasin A (EDA) monoclonal antibodies that induce ectodermal dysplasia.Translational genetics: advancing fronts for craniofacial health.Anti-EDAR Agonist Antibody Therapy Resolves Palate Defects in Pax9(-/-) Mice.Antibodies That Block or Activate Mouse B Cell Activating Factor of the Tumor Necrosis Factor (TNF) Family (BAFF), Respectively, Induce B Cell Depletion or B Cell Hyperplasia Small-molecule Wnt agonists correct cleft palates in Pax9 mutant mice in utero.Surface Plasmon Resonance (SPR) Analysis of Binding Interactions of Inner-Ear Proteins.Ectodysplasin A in Biological Fluids and Diagnosis of Ectodermal Dysplasia.

P2860

Q34542166-5952CC78-9C38-4234-BF8D-641254BECC6B Q34725505-93F49753-949C-486C-980D-AEE59B5067F4 Q36102789-BFBFFCF0-75AD-48A7-9381-2E3398220B8A Q36509470-56476F63-F779-4123-987B-650B03FFC769 Q36700398-07E9382C-663F-4BD3-9DD7-5BA0878D56C5 Q37140247-B69AA2D5-7726-4B3E-ACDF-5704D22E1470 Q37528944-30083111-7FB1-4370-A455-822A17B0707C Q37583543-A43FF9A8-91DD-453C-B902-722055AE85E9 Q38149843-086B9ED4-9771-4E14-8138-7AEADCC08490 Q38622294-4F4C17CF-4881-4326-8CF8-5FF518065FCF Q41106824-87962123-7E67-4746-8F44-D0BF6DE1E450 Q47820655-C98FE33D-31BE-4487-9860-C7B2FE38022C Q48695627-9B1F61D2-937D-41E5-B451-0FF1D4C202E9 Q50460455-17B0A951-401A-4BF3-B015-15E20BECC891

P2860

Molecular and therapeutic characterization of anti-ectodysplasin A receptor (EDAR) agonist monoclonal antibodies

http://www.wikidata.org/entity/Q35182967

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Molecular and therapeutic char ...... agonist monoclonal antibodies

@ast

Molecular and therapeutic char ...... agonist monoclonal antibodies

@en

type

label

Molecular and therapeutic char ...... agonist monoclonal antibodies

@ast

Molecular and therapeutic char ...... agonist monoclonal antibodies

@en

prefLabel

Molecular and therapeutic char ...... agonist monoclonal antibodies

@ast

Molecular and therapeutic char ...... agonist monoclonal antibodies

@en

P1433

Q35182967-227D6C24-EFAF-4E62-8130-DE3BF04B0BEC

P1476

Q35182967-8A25252D-A209-4393-9D90-8F57A65A6B47

P2093

Q35182967-126EB0B8-51AF-4126-9356-2ED55FAA5591

Q35182967-1E943BEC-CFB3-4427-8014-6FC49E423FF6

Q35182967-25050D07-7786-40A0-BBC6-606E36F622A7

Q35182967-321416DF-20BF-4402-9F1D-CB89FF9BA0C7

Q35182967-4A4216F6-FBE1-440E-B1BD-B95A4960B8C0

Q35182967-51ECCC56-C376-4F55-BA77-25EEC4575120

Q35182967-6EF00D9D-C429-4ED5-B60D-1B02607FB684

Q35182967-85EF65F0-43CB-433C-A59E-6A541AC951D7

Q35182967-8D388B66-4403-4833-A4A9-C54F6F59AE12

Q35182967-AAFE7CCE-E1C6-404D-8351-D4DC864B475A

P2860

Q35182967-1E927A7E-F2D4-4D31-93E3-F7BF27B2221D

Q35182967-1F1D557A-13E5-467B-B764-2D89544E9743

Q35182967-25830DAF-EFF3-415A-A5FA-B331A8AAE9E4

Q35182967-27D20FEF-CA83-4DF7-83AE-BA4EE0171C9B

Q35182967-2C395F2D-D340-47D5-91D3-EB26B8F8020D

Q35182967-43FB338D-4B9A-46B7-B6B3-5AAB0DC67C41

Q35182967-495E9CA1-DF03-4182-AB90-5811BE8150A3

Q35182967-52F3BEE9-E7C8-4D9E-A1E5-BE3BA428171B

Q35182967-546A5B13-E044-4506-AFA0-D3D4A9C47A80

Q35182967-581D9B14-E4C9-4013-B5BD-5FEF4BEA230E

P304

Q35182967-8C03E167-5CA1-4889-AB26-44D39B2CE5E4

P31

Q35182967-1F9BF384-1A5C-40C6-9250-A73C1870B7C9

P356

Q35182967-8091B074-2F39-494C-B032-1ACEC41A7905

P407

Q35182967-09E6B22D-5865-4333-AECB-B8C0C526D5CB

P433

Q35182967-C5200781-4D70-4781-A523-D956CBFC7B9A

P478

Q35182967-6D87460F-9C08-420E-B960-261162D43657

P577

Q35182967-BF7F2A82-A170-4823-890B-06ABF868C3AB

P698

Q35182967-3A013AA0-B670-4E32-9D20-20ED25588A45

P932

Q35182967-EB6D2F02-8DDE-4D79-BCBE-4154D0385DB8

P356

JBC.M111.267997

P1433

Journal of Biological Chemistry

P1476

Molecular and therapeutic char ...... agonist monoclonal antibodies

@en

P2093

Anne-Lise Etter

http://www.w3.org/2001/XMLSchema#string

Aubry Tardivel

http://www.w3.org/2001/XMLSchema#string

Christine Kowalczyk

http://www.w3.org/2001/XMLSchema#string

Denis J Headon

http://www.w3.org/2001/XMLSchema#string

Douglas M Jefferson

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Mauldin

http://www.w3.org/2001/XMLSchema#string

Giovanna Badic

http://www.w3.org/2001/XMLSchema#string

Laure Willen

http://www.w3.org/2001/XMLSchema#string

Manuel Favre

http://www.w3.org/2001/XMLSchema#string

Margret L Casal

http://www.w3.org/2001/XMLSchema#string

P2860

Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations

Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors

Gene defect in ectodermal dysplasia implicates a death domain adapter in development

Identification of a new splice form of the EDA1 gene permits detection of nearly all X-linked hypohidrotic ectodermal dysplasia mutations

Intercellular growth factor signaling and the development of mouse tracheal submucosal glands

Signalling pathways of the TNF superfamily: a double-edged sword

Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens.

Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.

A genetic study of anodontia in X-linked hypohidrotic ectodermal dysplasia.

P304

30769-30779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M111.267997

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21730053

http://www.w3.org/2001/XMLSchema#string

P932

3162438

http://www.w3.org/2001/XMLSchema#string